Fidson Healthcare Plc (NGX: FIDSON) has unveiled plans to raise fresh capital through a Rights Issue of 600 million ordinary shares as part of efforts to strengthen its balance sheet and support growth initiatives.
According to a market bulletin from the Nigerian Exchange (NGX), the pharmaceutical company — through its stockbrokers, CardinalStone Securities Limited and Imperial Asset Managers Limited — has submitted an application for the approval and listing of the new shares.
This was disclosed by the Head of Issuer Regulation Department at NGX Regulation Limited, Godstime Iwenekhai in a market bulletin on Wednesday. He noted that the application is currently under review for necessary approval and subsequent listing.
The Rights Issue is priced at ₦35.00 per share, with a nominal value of ₦0.50 per share. It will be offered on the basis of one (1) new ordinary share for every four (4) existing ordinary shares held by shareholders as at the close of business on Wednesday, November 12, 2025, which serves as the qualification date.
FIDSON is closed at N40 per share on the floor of the Nigerian Exchange on Wednesday.
The offer, if fully subscribed, will enable Fidson to raise ₦21 billion, providing additional funding for operational expansion, debt reduction, and working capital. The company’s outstanding shares will also increase from 2.29 billion to 2.89 billion.
With the Rights Issue, Fidson joins other listed firms (including Presco Plc, VFD Group Plc Ellah Lakes Plc, The Initiates among others) turning to the capital market to raise funds amid tight credit conditions and rising operational costs in Nigeria’s business environment.
Ifunanya Ikueze is an Engineer, Safety Professional, Writer, Investor, Entrepreneur and Educator.
